Suppr超能文献

相似文献

1
Revisiting rates of reactivation tuberculosis: a population-based approach.
Am J Respir Crit Care Med. 2010 Aug 1;182(3):420-5. doi: 10.1164/rccm.200909-1355OC. Epub 2010 Apr 15.
4
Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup.
Am J Epidemiol. 2014 Jan 15;179(2):216-25. doi: 10.1093/aje/kwt246. Epub 2013 Oct 18.
5
Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States.
Epidemiology. 2024 Mar 1;35(2):164-173. doi: 10.1097/EDE.0000000000001707. Epub 2023 Jan 30.
7
Risk of progression to active tuberculosis among foreign-born persons with latent tuberculosis.
Chest. 2007 Jun;131(6):1811-6. doi: 10.1378/chest.06-2601. Epub 2007 Apr 5.
8
Persistent latent tuberculosis reactivation risk in United States immigrants.
Am J Respir Crit Care Med. 2014 Jan 1;189(1):88-95. doi: 10.1164/rccm.201308-1480OC.
9
Latent Tuberculosis Infection Testing Strategies for HIV-Positive Individuals in Hong Kong.
JAMA Netw Open. 2019 Sep 4;2(9):e1910960. doi: 10.1001/jamanetworkopen.2019.10960.
10
Tuberculosis reactivation in referrals to public health clinics in Texas.
Am J Med Sci. 2013 Dec;346(6):442-6. doi: 10.1097/MAJ.0b013e318285f7db.

引用本文的文献

2
Community-Wide Active Case Finding for Tuberculosis: Time to Use the Evidence We Have.
Trop Med Infect Dis. 2024 Sep 14;9(9):214. doi: 10.3390/tropicalmed9090214.
4
Opinion review of drug resistant tuberculosis in West Africa: tackling the challenges for effective control.
Front Public Health. 2024 May 16;12:1374703. doi: 10.3389/fpubh.2024.1374703. eCollection 2024.
5
Cost-effectiveness of TB diagnostic technologies in Ethiopia: a modelling study.
Cost Eff Resour Alloc. 2024 May 21;22(1):43. doi: 10.1186/s12962-024-00544-1.
6
An Exploratory Review of the Potential of Lytic Proteins and Bacteriophages for the Treatment of Tuberculosis.
Microorganisms. 2024 Mar 12;12(3):570. doi: 10.3390/microorganisms12030570.
7
TB-free Ebeye: Results from integrated TB and noncommunicable disease case finding in Ebeye, Marshall Islands.
J Clin Tuberc Other Mycobact Dis. 2024 Feb 3;35:100418. doi: 10.1016/j.jctube.2024.100418. eCollection 2024 May.
8
Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States.
Epidemiology. 2024 Mar 1;35(2):164-173. doi: 10.1097/EDE.0000000000001707. Epub 2023 Jan 30.
10
Finding and treating both tuberculosis disease and latent infection during population-wide active case finding for tuberculosis elimination.
Front Med (Lausanne). 2023 Oct 16;10:1275140. doi: 10.3389/fmed.2023.1275140. eCollection 2023.

本文引用的文献

1
Latent TB infection treatment acceptance and completion in the United States and Canada.
Chest. 2010 Feb;137(2):401-9. doi: 10.1378/chest.09-0394. Epub 2009 Sep 30.
2
Risk of progression to active tuberculosis among foreign-born persons with latent tuberculosis.
Chest. 2007 Jun;131(6):1811-6. doi: 10.1378/chest.06-2601. Epub 2007 Apr 5.
3
Trends in tuberculosis incidence--United States, 2006.
MMWR Morb Mortal Wkly Rep. 2007 Mar 23;56(11):245-50.
4
Environmental risk factors for infection with Mycobacterium avium complex.
Am J Epidemiol. 2006 Jul 1;164(1):32-40. doi: 10.1093/aje/kwj159. Epub 2006 May 4.
5
The scope and impact of treatment of latent tuberculosis infection in the United States and Canada.
Am J Respir Crit Care Med. 2006 Apr 15;173(8):927-31. doi: 10.1164/rccm.200510-1563OC. Epub 2006 Jan 19.
7
Human immunodeficiency virus infection in a rural community in the United States.
Am J Epidemiol. 2004 Sep 15;160(6):582-8. doi: 10.1093/aje/kwh262.
8
Priorities for the treatment of latent tuberculosis infection in the United States.
N Engl J Med. 2004 May 13;350(20):2060-7. doi: 10.1056/NEJMsa031667.
10
A CONTROLLED TRIAL OF ISONIAZID PROPHYLAXIS IN MENTAL INSTITUTIONS.
Am Rev Respir Dis. 1963 Aug;88:161-75. doi: 10.1164/arrd.1963.88.2.161.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验